Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/22/2003CA2418930A1 Use of agents that modulate pde11a activity
08/21/2003WO2003069342A1 A method of screening
08/21/2003WO2003069341A2 Method of diagnosis of inflammatory diseases using calgranulin c
08/21/2003WO2003069337A1 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle)
08/21/2003WO2003069311A2 Methods and compositions for use in spliceosome mediated rna trans-splicing
08/21/2003WO2003069306A2 Protein carrier system for therapeutic oligonucleotides
08/21/2003WO2003068993A1 Method for isolation and purification of expressed gene products in vitro
08/21/2003WO2003068983A1 Use of the axl receptor for diagnosis and treatment of renal disease
08/21/2003WO2003068982A1 Bio-cell chip
08/21/2003WO2003068978A2 Combinations of vectors and the hosts thereof for the propagation and expression of recombinant genes without recourse to antibiotics
08/21/2003WO2003068976A2 Process for producing starch hydrolysate
08/21/2003WO2003068975A1 ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION
08/21/2003WO2003068973A1 Dna sequence useful in diagnosing hepatitis and polypeptide encoded thereby
08/21/2003WO2003068972A1 Ethylene-response trancriptional coactivators in plant
08/21/2003WO2003068971A1 Method of expressing an encoding sequence by xenoplus cells
08/21/2003WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene
08/21/2003WO2003068969A1 Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same
08/21/2003WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003WO2003068967A2 Novel retina specific human proteins wdr17, net01, protein kinase a203, protein kinase mak a194, protein a105, protein a106 and c12orf3variants
08/21/2003WO2003068966A2 REGULATION OF HUMAN Ca2+-PERMEABLE NONSELECTIVE CATION CHANNEL
08/21/2003WO2003068965A1 Isolated probes specific for g protein - coupled receptors and genes encoding same and diagnostic uses therefor
08/21/2003WO2003068964A1 Method of testing food
08/21/2003WO2003068963A1 Deoxyribozymes
08/21/2003WO2003068962A1 Separating method and an apparatus performing such a method
08/21/2003WO2003068961A2 Method to modify differentiation of pluripotential stem cells
08/21/2003WO2003068960A1 Transposon being functional in mammals
08/21/2003WO2003068958A1 Method of analyzing nucleic acid specifying gene showing change in expression dose due to schizophrenia
08/21/2003WO2003068957A1 METHOD OF SCREENING INK4 FAMILY GENE EXPRESSION CONTROLLER AND p19 GENE PROMOTER
08/21/2003WO2003068956A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003WO2003068955A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
08/21/2003WO2003068954A2 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003WO2003068952A1 Stat3 activated stem cell
08/21/2003WO2003068951A1 Ralstonia ahl-acylase gene
08/21/2003WO2003068950A1 Tissue-type plasminogen activator (t-pa) inhibitors with a therapeutic capacity
08/21/2003WO2003068948A1 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
08/21/2003WO2003068944A2 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1α-
08/21/2003WO2003068942A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
08/21/2003WO2003068941A2 Modulation of immune response by non-peptide binding stress response polypeptides
08/21/2003WO2003068939A2 Cks1 INHIBITORS
08/21/2003WO2003068934A2 Chimeric molecules for cleavage in a treated host
08/21/2003WO2003068933A2 Optimization of gene sequences of virus-like particles for expression in insect cells
08/21/2003WO2003068930A2 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
08/21/2003WO2003068929A2 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
08/21/2003WO2003068928A2 Gene function inferring using gene expression data
08/21/2003WO2003068926A2 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
08/21/2003WO2003068925A2 Production of a protein delivery system for in vivo therapeutic treatment
08/21/2003WO2003068923A2 Signal for packaging of influenza virus vectors
08/21/2003WO2003068917A2 Functionalization of carotenoid compounds
08/21/2003WO2003068915A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003WO2003068912A2 PSEUDOMONAS SYRINGAE HARPINS, HopPtoP AND HopPmaHPTO, AND THEIR USES
08/21/2003WO2003068911A2 Citrus tristeza virus resistance genes and methods of use
08/21/2003WO2003068908A2 Cardiotoxin molecular toxicology modeling
08/21/2003WO2003068821A2 Anti-cd20 antibodies and fusion proteins thereof and methods of use
08/21/2003WO2003068819A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003WO2003068818A1 Novel glutamate receptor and utilization thereof
08/21/2003WO2003068817A1 Management of mucosal viscosity by tff monomer peptides
08/21/2003WO2003068816A1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
08/21/2003WO2003068815A2 Mhc class ii peptide epitope of 5t4 antigen
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068810A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease
08/21/2003WO2003068809A2 An herpes simplex virus complex
08/21/2003WO2003068804A2 Novel insect cell line
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068802A2 Materials and methods for preparing dimeric growth factors
08/21/2003WO2003068798A2 Oligonucleotide analogues and methods of use for modulating gene expression
08/21/2003WO2003068797A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
08/21/2003WO2003068788A1 Method of isolating nucleic acids from stool samples
08/21/2003WO2003068787A1 Bi-functionalised metallocenes use for marking biological molecules
08/21/2003WO2003068712A2 Novel method for production of dna biochips and applications thereof
08/21/2003WO2003068201A2 High affinity antibody having a tcr-like specificity and use in detection and treatment
08/21/2003WO2003068190A1 Intracellular delivery of therapeutic agents
08/21/2003WO2003068169A2 Stabilized synthetic immunogen delivery system
08/21/2003WO2003068163A2 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
08/21/2003WO2003068153A2 CARDIAC-SPECIFIC 11β HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
08/21/2003WO2003068151A2 Human antibodies for therapy against vaccinia or smallpox
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003067965A2 Identification and characterization of an glutamine dumper 1 phenotype (gdui1) in arabidopsis
08/21/2003WO2003060142A9 Compositions and methods for controlled release
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003048352A3 Histone h3 methyltransferase polypeptide
08/21/2003WO2003046138A3 Genetically stable expression vector
08/21/2003WO2003045304A3 Mutable vaccines
08/21/2003WO2003045227A3 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
08/21/2003WO2003044176A8 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
08/21/2003WO2003042245A3 Growth hormone variations in humans and their uses
08/21/2003WO2003040394A3 Production of recombinant proteins in vivo and use for generating antibodies
08/21/2003WO2003037254A3 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
08/21/2003WO2003033674A3 Human antibodies that have mn binding and cell adhesion-neutralizing activity
08/21/2003WO2003031641A3 Beta 2 adrenergic polymorphism detection
08/21/2003WO2003029451A3 Histone deacetylase 9
08/21/2003WO2003029425A3 Whole cell engineering using real-time metabolic flux analysis
08/21/2003WO2003027300A3 Use of aminoglycoside resistance gene
08/21/2003WO2003027243A3 Phytate polynucleotides and methods of use
08/21/2003WO2003025176B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2003025144A3 Antisense modulation of ksr expression
08/21/2003WO2003025139A3 Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
08/21/2003WO2003024308A3 Methods of assaying connective tissue growth factor
08/21/2003WO2003022204A3 Measles vaccine vectors and methods of use
1 ... 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 ... 4023